rel-(1R,4R,7R)-2-Benzyl-7-bromo-2-azabicyclo[2.2.1]heptane

Catalog No. :
ACYIEO865
CAS No. :
312955-00-3
Molecular Formula :
C13H16BrN
Molecular Weight :
266.18

IUPAC Name:(1R,4R,7R)-2-benzyl-7-bromo-2-azabicyclo[2.2.1]heptane

rel-(1R,4R,7R)-2-Benzyl-7-bromo-2-azabicyclo[2.2.1]heptane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$206.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namerel-(1R,4R,7R)-2-Benzyl-7-bromo-2-azabicyclo[2.2.1]heptane
IUPAC Name(1R,4R,7R)-2-benzyl-7-bromo-2-azabicyclo[2.2.1]heptane
Molecular FormulaC13H16BrN
Molecular Weight266.18
SMILESBr[C@H]1[C@]2([H])N(CC3=CC=CC=C3)C[C@@]1([H])CC2
InChI KeyIOFSXPYIRVBNDN-JHJVBQTASA-N
SynonymANTI-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE;(1R,4R,7R)-7-BROMO-2-BENZYL-2-AZABICYCLO[2.2.1]HEPTANE;rel-(1R,4R,7R)-7-Bromo-2-(phenylmethyl)-2-azabicyclo[2.2.1]heptane;anti-7-Bromo-2-benzyl-2-azabicyclo[2.2.1]heptane racemate;2-Azabicyclo[2.2.1]heptane, 7-bromo-2-(phenylmethyl)-, (1R,4R,7R)-rel-;rel-(1R,4R,7R)-2-benzyl-7-bromo-2-azabicyclo[2.2.1]heptane
CAS No.312955-00-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYIEO865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYIEO865 route product structure diagram
    ACYIEO865312955-00-3
Inquiry

2. ACYIEO865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYIEO865 route product structure diagram
    ACYIEO865312955-00-3
Inquiry

Comments (0)